The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Open accessAbstract
The inhalation route is frequently used to administer drugs for the management of respiratory diseases such as asthma or chronic obstructive pulmonary disease. Compared with other routes of administration, inhalation offers a number of advantages in the treatment of these diseases. For example, via inhalation, a drug is directly delivered to the target organ, conferring high pulmonary drug concentrations and low systemic drug concentrations. Therefore, drug inhalation is typically associated with high pulmonary efficacy and minimal systemic side effects. The lung, as a target, represents an organ with a complex structure and multiple pulmonary-specific pharmacokinetic processes, including (1) drug particle/droplet deposition; (2) pulmonary drug dissolution; (3) mucociliary and macrophage clearance; (4) absorption to lung tissue; (5) pulmonary tissue retention and tissue metabolism; and (6) absorptive drug clearance to the systemic perfusion. In this review, we describe these pharmacokinetic processes and explain how they may be influenced by drug-, formulation- and device-, and patient-related factors. Furthermore, we highlight the complex interplay between these processes and describe, using the examples of inhaled albuterol, fluticasone propionate, budesonide, and olodaterol, how various sequential or parallel pulmonary processes should be considered in order to comprehend the pulmonary fate of inhaled drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models
Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997) · Toxicology and Industrial Health · doi:10.1177/074823379701300401 · Cited by 1,415
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Mucociliary clearance in the airways.
Wanner, A., Salathé, M., & O'Riordan, T. G. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.6.8970383 · Cited by 731
Rate-Limited Steps of Human Oral Absorption and QSAR Studies
Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B., & Cooper, I. (2002) · Pharmaceutical Research · doi:10.1023/a:1020444330011 · Cited by 717
Models of human lung airways and their application to inhaled particle deposition
Yeh, H.-C., & Schum, G. M. (1980) · Bulletin of Mathematical Biology · doi:10.1007/bf02460796 · Cited by 717
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
Lung development: orchestrating the generation and regeneration of a complex organ
Herriges, M., & Morrisey, E. E. (2014) · Development · doi:10.1242/dev.098186 · Cited by 613
Regional Lung Deposition and Bronchodilator Response as a Function of β 2 -Agonist Particle Size
Usmani, O. S., Biddiscombe, M. F., & Barnes, P. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1414oc · Cited by 578
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 563
Aerosol Deposition in Health and Disease
Darquenne, C. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0916 · Cited by 452
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01893.x · Cited by 451
Regulation of mucociliary clearance in health and disease
Houtmeyers, E., Gosselink, R., Gayan-Ramirez, G., & Decramer, M. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13e39.x · Cited by 422
Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung
Hukkanen, J., Pelkonen, O., Hakkola, J., & Raunio, H. (2002) · Critical Reviews in Toxicology · doi:10.1080/20024091064273 · Cited by 318
Inhalation drug delivery devices: technology update
Garcia-Contreras, L., Ibrahim, M., & Verma, R. (2015) · Medical Devices: Evidence and Research · doi:10.2147/mder.s48888 · Cited by 306
Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Vauquelin, G., & Charlton, S. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00936.x · Cited by 298
Zhou, Q., Jin, J.-F., Zhu, L.-L., Chen, M., Xu, H.-M., Wang, H.-F., Feng, X.-Q., & Zhu, X.-P. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87271 · Cited by 296
Ruge, C. A., Kirch, J., & Lehr, C.-M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70072-9 · Cited by 280
Particle Transport and Deposition: Basic Physics of Particle Kinetics
Tsuda, A., Henry, F. S., & Butler, J. P. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c100085 · Cited by 264
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Daley‐Yates, P. T. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12637 · Cited by 260
Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y., Guengerich, F. P., & Inui, Y. (1996) · PubMed · Cited by 244
Shaykhiev, R., Otaki, F., Bonsu, P., Dang, D. T., Teater, M., Strulovici-Barel, Y., Salit, J., Harvey, B.-G., & Crystal, R. G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0500-x · Cited by 228
Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds
Fröhlich, E., Mercuri, A., Wu, S., & Salar-Behzadi, S. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00181 · Cited by 222
The potential role of lysosomes in tissue distribution of weak bases
Macintyre, A. C., & Cutler, D. J. (1988) · Biopharmaceutics & Drug Disposition · doi:10.1002/bod.2510090602 · Cited by 208
Omiecinski, C. J., Redlich, C. A., & Costa, P. (1990) · PubMed · Cited by 187
Alveolar Macrophages Transport Pathogens to Lung Draining Lymph Nodes
Kirby, A. C., Coles, M. C., & Kaye, P. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901089 · Cited by 184
Pulmonary Drug Metabolism, Clearance, and Absorption
Olsson, B., Bondesson, E., Borgström, L., Edsbäcker, S., Eirefelt, S., Ekelund, K., Gustavsson, L., & Hegelund-Myrbäck, T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9745-6_2 · Cited by 183
Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids
Johnson, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80217-x · Cited by 161
Expression and Localization of CYP3A4 and CYP3A5 in Human Lung
Anttila, S. L., Hukkanen, J., Hakkola, J., Stjernvall, T., Beaune, P. H., Edwards, R. J., Boobis, A. R., Pelkonen, O., & Raunio, H. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.3.9070608 · Cited by 154
Innate Host Defense of the Lung: Effects of Lung-lining Fluid pH
Ng, A. W., Bidani, A., & Heming, T. A. (2004) · Lung · doi:10.1007/s00408-004-2511-6 · Cited by 153
Dry powder inhalers and the right things to remember: a concept review
Negro, R. W. D. (2015) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-015-0012-5 · Cited by 143
Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects
Henry, R. R., Mudaliar, S. R. D., Howland, W. C., Chu, N. V., Kim, D. S., An, B., & Reinhardt, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.764 · Cited by 133
The importance of inhaler devices in the treatment of COPD
Bonini, M., & Usmani, O. S. (2015) · COPD Research and Practice · doi:10.1186/s40749-015-0011-0 · Cited by 116
Absorption of aerosolized drugs from the rat lung.
Brown, R. A., & Schanker, L. S. (1983) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08032-8 · Cited by 109
Methods to identify drug deposition in the lungs following inhalation
Chrystyn, H. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01304.x · Cited by 106
Pharmacokinetic/Pharmacodynamic Aspects of Aerosol Therapy using Glucocorticoids as a Model
Hochhaus, G., Möllmann, H., Derendorf, H., et al. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04262.x · Cited by 106
Differences in Airway Remodeling Between Asthma and Chronic Obstructive Pulmonary Disease
Aoshiba, K., & Nagai, A. (2004) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:27:1:035 · Cited by 105
Pulmonary surfactants and their role in pathophysiology of lung disorders.
Akella, A., & Deshpande, S. B. (2013) · PubMed · Cited by 101
Harrison, T. W. (2003) · Thorax · doi:10.1136/thorax.58.3.258 · Cited by 98
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
Forbes, B., O’Lone, R. B., Pribul, P. K., Cahn, A. P., Clarke, C. J., Collinge, M., Dailey, L. A., Donnelly, L., Dybowski, J. A., Hassall, D. G., et al. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.001 · Cited by 97
Schanker, L. S., Mitchell, E. W., & Brown, R. A. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08279-0 · Cited by 91
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs
Borghardt, J. M., Weber, B., Staab, A., & Kloft, C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9760-6 · Cited by 89
Self-citationLung mucus: a clinician's view
Kim, W. D. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10081914 · Cited by 88
Harrison, T. W., Wisniewski, A., Honour, J., & Tattersfield, A. E. (2001) · Thorax · doi:10.1136/thorax.56.3.186 · Cited by 88
Bäckman, P., Arora, S., Couet, W. R., Forbes, B., de Kruijf, W., & Paudel, A. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.10.030 · Cited by 76
Boger, E., Evans, N. D., Chappell, M. J., Lundqvist, A. J., Ewing, P., Wigenborg, A., & Fridén, M. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12074 · Cited by 69
Drug Delivery to the Small Airways
Thompson, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.rsaa-7 · Cited by 58
The impact of pulmonary diseases on the fate of inhaled medicines—A review
Wang, Y.-B., Watts, A. B., Peters, J. I., & Williams, R. O. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.042 · Cited by 56
Bartels, C., Looby, M., Séchaud, R., & Kaiser, G. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12118 · Cited by 51
Itoh, H., Nishino, M., & Hatabu, H. (2004) · Journal of Thoracic Imaging · doi:10.1097/01.rti.0000142835.06988.b0 · Cited by 50
Inhaled versus oral steroids for adults with chronic asthma
Mash, B. R., Bheekie, A., & Jones, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002160 · Cited by 50
Sakagami, M. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443080-00004 · Cited by 48
Development of a Novel Lung Slice Methodology for Profiling of Inhaled Compounds
Bäckström, E., Lundqvist, A. J., Boger, E., Svanberg, P., Ewing, P., Hammarlund‐Udenaes, M., & Fridén, M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24575 · Cited by 40
Camberlein, E., Cohen, J., José, R. J. P., Hyams, C. J., Callard, R. E., Chimalapati, S., Yuste, J., Edwards, L. A., Marshall, H., van Rooijen, N., et al. (2015) · Infection and Immunity · doi:10.1128/iai.02788-14 · Cited by 39
Jendbro, M., Johansson, C. J., Strandberg, P., Falk-Nilsson, H., & Edsbäcker, S. (2001) · PubMed · Cited by 35
The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
Usmani, O. S., Biddiscombe, M. F., Yang, S., Meah, S., Oballa, E., Simpson, J. K., Fahy, W. A., Marshall, R. P., Lukey, P. T., & Maher, T. M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0732-0 · Cited by 33
Lung Retention by Lysosomal Trapping of Inhaled Drugs Can Be Predicted In Vitro With Lung Slices
Bäckström, E., Boger, E., Lundqvist, A. J., Hammarlund‐Udenaes, M., & Fridén, M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.08.014 · Cited by 28
Uncovering the regional localization of inhaled salmeterol retention in the lung
Bäckström, E., Hamm, G. R., Nilsson, A., Fihn, B., Strittmatter, N., Andrén, P. E., Goodwin, R. J. A., & Fridén, M. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1455762 · Cited by 20
Melin, J., Prothon, S., Kloft, C., Cleton, A., Amilon, C., Jorup, C., Bäckman, P., Olsson, B., & Hamrén, U. W. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0042-8 · Cited by 15
Self-citation
Metadata
- Authors
- Borghardt, J. M., Kloft, C., & Sharma, A.
- Venue
- Canadian Respiratory Journal
- Publisher
- Wiley
- Published
- 2018-06-19
- Volume
- 2018
- Pages
- 1-11
- ISSN
- 1198-2241 (ISSN-L)
- 1916-7245
- OpenAlex
- W2809422875
- Cited by
- 304
- References
- 63
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.